We are offering the product from our Indian manufacturer’s USFDA, Japan PMDA, Korea FDA approved site. Their facility is COFEPRIS inspected for several products. Their R&D facility is recognized by the Department of Scientific and Industrial Research (DSIR, Ministry of Science and Technology, Government of India).
(1S,2S,3S,4R)-3-[(1S)-1-Amino-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-cyclopentanecarboxylic acid methyl ester
Additional information
| Product Name | (1S, 1-dimethylethoxy)carbonyl]amino]-2-hydroxy-cyclopentanecarboxylic acid methyl ester, 2S, 3S, 4R)-3-[(1S)-1-Amino-2-ethylbutyl]-4-[[(1 |
|---|---|
| CAS Registry No | 316173-29-2 |
| Specification | In-House |
| Synonyms | (1S, 1-dimethylethoxy)carbonyl]amino]-2-hydroxy-cyclopentanecarboxylic acid methyl ester, 2S, 3S, 4R)-3-[(1S)-1-Amino-2-ethylbutyl]-4-[[(1 |
| Molecular Formula | C18H34N2O5 |
| Molecular Weight | 358.47 |
| MSDS Description | Available on request |
| Availability | For Research and Development Purpose |
| Application | Antiviral |
![(1S,2S,3S,4R)-3-[(1S)-1-Amino-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-cyclopentanecarboxylic acid methyl ester](https://manusakttevabiopharma.com/wp-content/uploads/2021/12/316173-29-2.jpg)